Advances in continuous renal replacement therapy: Citrate anticoagulation update

Blood Purification

Volumn 34, Issue 2, 2012, Pages 88-93

  Tolwani, Ashita ^a   Wille, Keith M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Continuous renal replacement therapy; Heparin induced thrombocytopenia; Regional citrate anticoagulation

Indexed keywords

ACID CITRATE DEXTROSE; CITRIC ACID; HEPARIN; NADROPARIN;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; ARTICLE; BIOCOMPATIBILITY; BLEEDING; BLOOD FLOW; BLOOD GAS ANALYSIS; CALCIUM BLOOD LEVEL; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIALYSIS CATHETER; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; DRUG TOXICITY; EXTRACORPOREAL CIRCULATION; HUMAN; HYPERCALCEMIA; HYPERLACTATEMIA; HYPERNATREMIA; HYPOCALCEMIA; HYPONATREMIA; INCIDENCE; INFUSION RATE; LIVER GRAFT; META ANALYSIS; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ACIDOSIS; ACUTE KIDNEY INJURY; ALKALOSIS; ANTICOAGULANTS; CITRATES; HEPARIN; HUMANS; HYPERNATREMIA; HYPOCALCEMIA; HYPONATREMIA; RENAL REPLACEMENT THERAPY;

EID: 84867954679     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000342378     Document Type: Article

References (21)

1. Amanzadeh J, Reilly RF: Anticoagulation and continuous renal replacement therapy. Semin Dial 2006; 19: 311-316.
2. Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H: Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation. Nephron 2001; 89: 233-236.
3. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for haemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-261.
4. Davenport A, Tolwani A: Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. Nephrol Dial Transplant Plus 2009; 2: 439-447.
5. Meier-Kriesche HU, Gitomer J, Finkel K, Du Bose T: Increased total to ionised calcium ratio during continuous venovenous haemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29: 748-752.
6. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31: 2450-2455.
7. Saner F, Treckmann J, Geis A, Lösch C, Witzke O, Canbay A, Herget-Rosenthal S, Kribben A, Paul A, Feldkamp T: Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant 2012; 27: 1651-1657.
8. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous haemodialysis in critically ill patients. Kidney Int 1990; 38: 976-981.
9. Oudemans-van Straaten HM, Fiaccadori, Baldwin I: Anticoagulation for renal replacement therapy: Different methods to improve safety. Practice of renal replacement therapy in the ICU; in Ronco C, Bellomo R, Mc-Cullough PA (eds): Cardiorenal Syndromes in Critical Care. Contrib Nephrol. Basel, Karger, 2010, 165, pp 251-262.
10. Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer H: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009; 37: 2018-2024.
11. Tolwani AJ, Prendergast MB, Speer RR, Wille KM: A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1: 79-87.
12. Zhang Z, Hongying N: Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012; 38: 20-28.
13. Bos JC, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nube MJ: Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997; 12: 1387-1393.
14. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, Kapiotis S, Druml W: Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999; 56: 1578.
15. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate vs heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30: 260-265.
16. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67: 2361-236.
17. Betjes MG, van Oosterom D, van Agteren M, van de Wetering J: Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: Similar hemofilter survival but significantly less bleeding. J Nephrol 2007; 20: 602-608.
18. Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R: A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration. Int J Artif Organs 2007; 30: 301-307.
19. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF: Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37: 545-552.
20. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC: Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: A prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232-239.
21. Wu M, Hsu Y, Bai C, Lin Y, Wu C, Tam K: Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A meta-Analysis of randomized controlled trials. Am J Kidney Dis 2012; 59: 810-818.